Point-of-injury intranasal ALM drug therapy to reduce secondary injury and improve outcomes after TBI in civilian and military resource-limited environments

Ended Project Grant Awarded Last action

Award ID
HT94252310917
Recipient
Awarding agency
Obligated
$613,585

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Australia

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

This Project Grant award of $613,585.00 from the Defense Health Agency (DHA) supports research by James Cook University's Australian Institute of Tropical Health and Medicine to develop point-of-injury intranasal drug therapies to reduce secondary injury and improve outcomes for individuals with traumatic brain injuries (TBIs) in civilian and military resource-limited environments. This research falls under the DHA's Military Medical Research and Development program (CFDA 12.420), which focuses on transforming healthcare for Service Members and the public through innovative medical solutions for the battlefield. The award will fund the development of these intranasal drug therapies over a 3-year period from September 1, 2023 to August 31, 2026.

Quick answers

Who received award HT94252310917?

HT94252310917 was awarded to James Cook University by Defense Health Agency (Department of Defense) on September 1, 2023.

How much is award HT94252310917 worth?

$613,585 has been obligated on HT94252310917.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login